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Abstract. 
 
The E-cadherin/catenin complex regulates 
 
Ca
 
11
 
-dependent cellÐcell adhesion and is localized to 
the basal-lateral membrane of polarized epithelial cells. 
Little is known about mechanisms of complex assembly 
or intracellular trafficking, or how these processes 
might ultimately regulate adhesion functions of the 
complex at the cell surface. The cytoplasmic domain of 
E-cadherin contains two putative basal-lateral sorting 
motifs, which are homologous to sorting signals in the 
low density lipoprotein receptor, but an alanine scan 
across tyrosine residues in these motifs did not affect 
the fidelity of newly synthesized E-cadherin delivery to 
the basal-lateral membrane of MDCK cells. Neverthe-
less, sorting signals are located in the cytoplasmic do-
main since a chimeric protein (GP2CAD1), comprising 
the extracellular domain of GP2 (an apical membrane 
protein) and the transmembrane and cytoplasmic do-
mains of E-cadherin, was efficiently and specifically de-
livered to the basal-lateral membrane. Systematic dele-
tion and recombination of specific regions of the 
cytoplasmic domain of GP2CAD1 resulted in delivery 
 
of 
 
,
 
10% of these newly synthesized proteins to both 
apical and basal-lateral membrane domains. Signifi-
cantly, 
 
.
 
90% of each mutant protein was retained in 
the ER. None of these mutants formed a strong interac-
tion with 
 
b
 
-catenin, which normally occurs shortly after 
E-cadherin synthesis. In addition, a simple deletion mu-
tation of E-cadherin that lacks 
 
b
 
-catenin binding is also 
localized intracellularly. Thus, 
 
b
 
-catenin binding to the 
whole cytoplasmic domain of E-cadherin correlates 
with efficient and targeted delivery of E-cadherin to the 
lateral plasma membrane. In this capacity, we suggest 
that 
 
b
 
-catenin acts as a chauffeur, to facilitate transport 
of E-cadherin out of the ER and the plasma membrane.
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E
 
PITHELIAL
 
 cells form barriers that separate the inter-
nal milieu from the outer environment of multicel-
lular organisms, and vectorially transport ions and
solutes between these compartments. To perform these
functions, these cells form cellÐcell contacts through cad-
herin adhesion proteins, establish tight seals between cellÐ
cell contacts (tight junctions), and organize the plasma
 
membrane into structurally and functionally distinct
domains, termed apical and basal-lateral, that face these
different compartments (Rodriguez-Boulan and Nelson,
1989).
Localization of transmembrane proteins to specific
plasma membrane domains is achieved by protein sorting
in the Golgi and subsequent delivery to specific membrane
domains, and by selective retention of proteins in the
plasma membrane (Nelson, 1992). Molecular mechanisms
involved in protein sorting and delivery are poorly under-
stood. To date, the only identified sorting signal for apical
membrane proteins in MDCK cells is a glycosylphosphoti-
 
dylinositol (GPI)
 
1
 
 linkage (Brown et al., 1989; Lisanti et al.,
1989; for a recent review, see Nosjean et al., 1997). How
the lipid anchor specifies apical domain-specific sorting
and targeting in the TGN is not clear. It has been proposed
that the GPI anchor enables the protein to enter glyco-
sphingolipid clusters and, thereby, to be sorted to the
apical membrane domain (Simons and Wandinger, 1990;
Weimbs et al., 1997).
Several amino acid motifs have been identified that
specify type-I transmembrane protein sorting in the TGN
and delivery to the basal-lateral membrane (Rodriguez-
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Boulan and Powell, 1992; Matter and Mellman, 1994;
Weimbs et al., 1997). These motifs are located in the cyto-
plasmic domain and include tyrosine-based sorting signals
of VSV-G (Thomas et al., 1993) and LDL receptor (LDL-R;
Matter et al., 1992), non-tyrosine-based signals of the poly-
meric immunoglobulin receptor (pIgR; Casanova et al.,
1991), and the di-leucine motif of Fc receptor (Hunziker
and Fumey, 1994; Matter et al., 1994). It is noteworthy that
these proteins are not known to associate with heterolo-
gous membrane protein binding partners or accessory pro-
teins in the secretory pathway.
E-cadherin, a type-I single-span transmembrane pro-
tein, is an endogenous adhesion molecule of epithelial
cells (Kemler, 1992). E-cadherin mediates cellÐcell adhe-
sion by calcium-dependent homotypic interactions between
E-cadherin extracellular domains on opposing membranes
of contacting cells (Nagafuchi et al., 1987). However,
strong adhesion requires linkage of the cytoplasmic do-
main of E-cadherin to the actin cytoskeleton (Nagafuchi
and Takeichi, 1988). This linkage is mediated by direct
binding of 
 
b
 
-catenin to the cytoplasmic domain of E-cad-
herin (Aberle et al., 1994; Jou et al., 1995); the minimal
 
b
 
-catenin binding site on E-cadherin is thought to be a 30Ð
amino acid basic sequence in the middle of the cyto-
plasmic domain (Stappert and Kemler, 1994). In turn,
 
b
 
-catenin binds 
 
a
 
-catenin (Aberle et al., 1994; Jou et al.,
1995), which links the cadherin/catenin complex directly
(Rimm et al., 1995) or indirectly (Knudsen et al., 1995) to
the actin cytoskeleton. The stoichiometry of the E-cad-
herin/
 
b
 
-catenin/
 
a
 
-catenin complex is 1:1:1 (Ozawa and
Kemler, 1992; Hinck et al., 1994a). Finally, evidence has
accumulated that E-cadherin forms dimers through inter-
actions between the extracellular and/or membrane proxi-
mal domains of adjacent proteins (Shapiro et al., 1995;
Brieher et al., 1996; Nagar et al., 1996; Yap et al., 1998). In
polarized MDCK cells, E-cadherin is localized to the lat-
eral membrane (Le Bivic et al., 1990; Shore and Nelson,
1991), and newly synthesized E-cadherin is preferentially
sorted in the Golgi and delivered directly to the basal-lat-
eral membrane (Le Bivic et al., 1990). Mechanisms regu-
lating assembly of the cadherin/catenin complex and tar-
geting of E-cadherin to its site of function at the lateral
membrane domain are unknown.
We are interested in the relationship between intracellu-
lar trafficking of membrane proteins and cellÐcell adhe-
sion. Previous studies reported that 
 
b
 
-catenin binds to the
cytoplasmic domain of E-cadherin shortly after E-cad-
herin synthesis, while 
 
a
 
-catenin joins the complex later,
probably after E-cadherin has reached the cell surface
(Ozawa et al., 1990; Hinck et al., 1994a). Thus, unlike other
type-I membrane proteins studied (see above), E-cadherin
is sorted and targeted to the basal-lateral membrane in a
stoichiometric complex with a cytosolic protein, 
 
b
 
-catenin.
This prompted us to explore the relationship between
E-cadherin sorting to the basal-lateral membrane domain
and assembly of the E-cadherin/
 
b
 
-catenin complex. There
are two regions of the cytoplasmic domain of E-cadherin
which are similar in amino acid sequence to previously
identified basal-lateral sorting signals of LDL-R (Matter
et al., 1992), i.e., a sequence motif of Y---XXX, where X is
an acidic amino acid residue. The first putative sorting sig-
nal in E-cadherin is immediately proximal to the trans-
 
membrane domain and the other is at the extreme COOH
terminus, also similar to the locations of the two sorting
signals in LDL-R cytoplasmic domain (see Fig. 1). We
show that despite these similarities, mutations of tyrosine
to alanine in those two potential basal-lateral sorting sig-
nals in E-cadherin do not affect sorting of newly synthesized
mutant E-cadherin in MDCK cells. Further dissection of
the cytoplasmic domain of E-cadherin using a chimeric
protein approach revealed that E-cadherin exit from the
ER and efficient sorting to the basal-lateral membrane are
coupled to assembly of the E-cadherin/
 
b
 
-catenin complex
shortly after E-cadherin synthesis.
 
Materials and Methods
 
Antibodies
 
Monoclonal antibody against rat GP2 has been described previously
(Mays et al., 1995) and was a gift from Dr. Anson Lowe (Stanford Univer-
sity). Monoclonal antibody KT3 against SV-40 large T antigen (Mac-
Arthur and Walter, 1984) was a gift from Dr. Gernot Walter (University
of California, San Diego, CA). Polyclonal antibody against the cytoplas-
mic domain of cadherin has been described previously (Marrs et al., 1993).
Monoclonal antibody against human CD7 (T3.3A1) was obtained from
American Type Culture Collection.
 
Recombinant cDNA Construction
 
Due to the numerous recombinant cDNA constructs used in this study
and that some constructs are derivatives in nature, construction details are
not described for all constructs but are available upon request (E-mail:
etchen@cmgm.stanford.edu). Individual constructs were confirmed by re-
striction mapping and DNA sequencing (PAN facility, Stanford Univer-
sity).
 
Plasmid for Expression of E-cad
 
sol
 
. 
 
U-GFP, a previously unpublished
plasmid based on CDM8 (Aruffo and Seed, 1987a,b), containing a fusion
protein with the extracellular domain of canine E-cadherin jointed with
green fluorescent protein (GFP), was the starting material. The chimeric
coding region is flanked by Hind3 and Not1 sites at the 5
 
9
 
 and 3
 
9
 
 end, re-
spectively, with a Xho1 site as a linker (reading frame CTC-GAG, Leu-
Glu) between the E-cadherin extracellular domain and GFP. The majority
of the cadherin region (Hind3-Xho1, 2.1 kb) is derived from a cDNA
clone (Hind3-Bgl2, 1.9 kb). The small remaining portion of the cadherin
extracellular domain (Bgl2-Xho1, 0.2 kb) was from a PCR product. The
GFP region was replaced with a pair of complimentary oligonucleotides
encoding for the epitope tag of KT3 (amino acid sequence KPPTP-
PPEPET) and a stop codon, while retaining the Xho1 linker and the 3
 
9
 
-
end Not1 site. The resulting plasmid is named U-SVLT1. The encoded
soluble, KT3-tagged extracellular domain of canine E-cadherin is named
E-cad
 
sol
 
. A PCR reaction was carried out to amplify the coding region of
E-cadherin from the internal endogenous Bgl2 site to the end of the cod-
ing region (the stop codon was replaced with a Xho1 site), using canine
E-cadherin cDNA (a gift from Dr. Lee Rubin, University College Lon-
don, UK) as the template. Note that the PCR product contains a small
part of the extracellular domain and the complete transmembrane and cy-
toplasmic domains of E-cadherin and, after restricting with Bgl2 and
Xho1, was used to replace the Bgl2 and Xho1 portion of U-SVLT1, result-
ing in the plasmid U-SVLT2. Thus, U-SVLT2 encodes a complete canine
E-cadherin fused with KT3 epitope tag through a Xho1 (Leu-Glu) linker.
Further mutagenesis of the putative basal-lateral sorting signals was car-
ried out by PCR reactions to amplify the region of the Bgl2/Xho1 of
U-SVLT2, as detailed below.
 
Plasmids for Expression of E-cad BL1, BL2, and BL12. 
 
Plasmid U-SVLT3,
 
which encodes the mutant protein E-cadherin BL2 (Y
 
®
 
A mutations in
BL2), was generated by PCR using the pair of oligonucleotides Cad BL-P6
(5
 
9
 
-CGC GGG CCA GAT CTT CCC CCC AAC ACA TCT-3
 
9
 
; Bgl2 site
is underlined) and Cad BL-P3 (5
 
9
 
-CGC GGG CTC GAG GTC GTC CTC
GCC ACC GCC GGC CAT GTC CGC CAG CTT-3
 
9
 
; Nae1 site is under-
lined). Note that the mutations introduced were accompanied by the in-
troduction of a Nae1 site. The PCR product was used to replace the Bgl2
and Xho1 portion of U-SVLT2. Plasmid U-SVLT5, which encodes the
mutant protein E-cadherin BL1 (Y
 
®
 
A mutations in BL1), was generated 
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by PCR from three reactions. A complimentary pair of oligonucleotides,
Cad BL-P4 (5
 
9
 
-GAC ACC CGG GAC AAT GTT 
 
GCA GCT GC
 
A GAT
GAA GAA GGA GGT GG-3
 
9
 
) and Cad BL-P5 (5
 
9
 
-CCA CCT CCT TCT
TCA T
 
CT GCA GCT GC
 
A ACA TTG TCC CGG GTG TC-3
 
9
 
), encode
the (Y
 
®
 
A) mutations (italics in the sequences given above) and were syn-
thesized. Note that the introduction of a Pst1 site (underlined, CTGCAG)
accompanied the introduction of the mutations. Two PCR reactions were
carried out with pairs of oligonucleotides Cad BL-P6 (sense) and Cad BL-
P5 (anti-sense), Cad BL-P4 (sense) and Cad BL-P2 (antisense, 5
 
9
 
-GCG
CCC CTC GAG GTC GTC CTC GCC ACC TCC-3
 
9
 
; Xho1 site is under-
lined). The reaction products were mixed and served as the template for
the third reaction with a pair of oligonucleotides, Cad BL-P6 (sense), and
Cad BL-P2 (antisense). The PCR product was subcloned and replaced the
Bgl2-Xho1 portion of the U-SVLT2 to give rise to U-SVLT5.
The plasmid U-SVLT4 which encodes E-cadherin BL12 (Y
 
®
 
A muta-
tion in BL1 and BL2) was constructed in an identical manner as that used
to construct U-SVLT5, except oligonucleotide Cad BL-PL3 was used in
place of Cad BL-P2. Note that in the series of plasmids U-SVLT3, 4, and
5, the identity of the introduced mutations were checked by the presence
of the Pst1 and/or Nae1 restriction sites.
 
GP2S. 
 
Amino acids (aa) 1Ð504 of the coding region of rat GP2 cDNA
(a gift from Dr. Anson Lowe, Stanford University) was amplified by PCR
with a stop codon introduced downstream to amino acid 504, and with
Hind3 and Not1 sites added to the 5
 
9
 
 and 3
 
9
 
 ends, respectively. The PCR
product was subcloned into CDM8 through Hind3 and Not1 sites and re-
sulted in the plasmid, GP2S.
 
GP2CAD1. 
 
GP2CAD1 is a chimeric protein of rat GP2 in which the
GPI modification signal has been deleted (named GP2
 
D
 
GPI), and the
transmembrane domain and cytoplasmic domain of canine E-cadherin
added. To create GP2CAD1, the following oligonucleotides were used as
PCR primers: a pair of complimentary oligonucleotides with the COOH
terminus sequence of rat GP2 (without the GPI modification signal)
joined in-frame with canine E-cadherin transmembrane sequence (italic),
GP2CAD1-1S (5
 
9
 
-CAG AAT CCT GAT ACC TCC 
 
GCG CCT TAC
GCC GAA GCA
 
-3
 
9
 
) and GP2CAD1-3A (5
 
9
 
-
 
TGC TTC GGC GTA AGG
CGC
 
 GGA GGT ATC AGG ATT CTG-3
 
9
 
); an oligonucleotide hybridiz-
ing with the COOH terminus of canine E-cadherin, including the stop
codon, GP2CAD1-2A (5
 
9
 
-CGC GGG GCG GCC GCT TTA GTC GTC
CTC GCC ACC TCC); an oligonucleotide hybridizing with the NH
 
2
 
 ter-
minus of GP2, including the start codon, GP2-1S (5
 
9
 
-CGC GGG AAG
CTT AGG ATG GTG GCT TGT GAC-3
 
9
 
). Primers GP2-1S and
GP2CAD1-3A were used to amplify GP2 using a cDNA clone of rat GP2.
Primer GP2CAD1-2A was used with primer GP2CAD1-1S to amplify the
transmembrane and cytoplasmic domains of canine E-cadherin using a
cDNA clone of canine E-cadherin as the template. The PCR products
from the two reactions were mixed and used as template for amplification
using oligonucleotides GP2-1S and GP2CAD1-2A as primers. The final
PCR product was then subcloned into the Hind3-Not1 sites of CDM8, and
the plasmid was named GP2CAD1. GP2CAD1 was then used as the tem-
plate to create chimeric proteins in the following section.
 
GP2CAD1 Truncation Mutants. 
 
GP2CAD2, 4, 6, 7, 8, and 10 are simple
truncation mutants of GP2CAD1. GP2CAD1 was used as the PCR tem-
plate. Individual antisense oligonucleotides hybridizing with the 6 aa up-
stream to the desired truncation, with a stop codon and Not1 site, were
used with the oligonucleotide primer GP2-3S (5
 
9
 
-CGC GGG CAA GTC
GAC TTC GCA GTA GTG AAC C-3
 
9
 
), which hybridizes to the region
of the endogenous Sal1 site (underlined in the sequence) close to the
COOH terminus of GP2 coding region, for individual PCR reactions to
amplify parts of the cytoplasmic domain of E-cadherin. The resulting PCR
products were cloned into GP2CAD1 through Sal1-Not1 sites. The cyto-
plasmic domain carried by each chimeric protein is shown in the diagram
in Fig. 4, and described in detail in the Results section.
GP2CAD3 is a loop-out mutant constructed using a method similar to
that used in the construction of GP2CAD1. A pair of complimentary oli-
gonucleotides with the sequence corresponding to aa 77Ð82 and 130Ð135
of the cytoplasmic domain of E-cadherin were joined. The primer pair
was used with oligonucleotides GP2-3S and GP2CAD1-2A to create
GP2CAD3 using recombinant PCR reactions identical to those used to
construct U-SVLT4 and GP2CAD1.
The other loop-out mutants, GP2CAD5 and GP2CAD9, were con-
structed in a similar manner as follows: aa 83Ð129 (BB1) of the cytoplas-
mic domain of canine E-cadherin were PCR amplified using the canine
cDNA clone as template with a Xho1 site added to the 5
 
9
 
 end and a Not1
site added to the 5
 
9
 
 end downstream to a stop codon. The PCR product
was subcloned into CDM8FluTag (Chen et al., 1993) through Xho1 and
Not1 sites and resulted in an in-frame fusion with the influenza virus
hemagglutinin tag. The resulting plasmid was named HA-BB1. A PCR re-
action were carried out to amplify the GP2 and the transmembrane do-
main of E-cadherin from GP2CAD1 to replace the HA portion in HA-
BB1. The resulting plasmid encodes the chimeric protein GP2CAD5,
which comprises GP2 and the transmembrane domain of E-cadherin
fused with 83Ð129 of the cytoplasmic domain through a Xho1 linker (Leu-
Glu). GP2CAD9 was constructed similarly.
 
CD7BB1. 
 
A human CD7 cDNA clone, CD7-31 (a gift from Dr. Brian
Seed, Harvard University Medical School), was in a CDM8-based expres-
sion vector (Aruffo and Seed, 1987b) and was used directly for transfec-
tion. CD7-31 was used as the template for PCR to amplify the complete
coding region of CD7 with Hind3 and Xho1 sites added to the 5
 
9
 
 and 3
 
9
 
ends, respectively. The amplified CD7 was subcloned into HA-BB1
through Hind3 and Xho1 site which generated an in-frame fusion of CD7
and BB1. The resulting plasmid was named CD7BB1.
 
E-cad8. 
 
E-cad8 is a canine E-cadherin deletion mutant with 116Ð151
(the most COOH-terminal 36 aa) of the cytoplasmic domain deleted. The
deletion in cytoplasmic domain is equivalent to that in GP2CAD8. Oligo-
nucleotides Cad BL-P6 (see above) and E-CAD8-A (5
 
9
 
-CGC GGG CTC
GAG GCT CAG ACT AGC AGC TTC AGA-3
 
9
 
, the Xho1 site is under-
lined) were used to perform PCR using canine E-cadherin cDNA as the
template. The PCR product was restrited with Xho1 and Bgl2, and then
was subcloned into the plasmid U-SVLT1 after the Bgl2 and Xho1 diges-
tion. The ligation resulted in an in-frame fusion with KT3 epitope tag
through the Xho1 site with Leu-Glu as a linker at the COOH terminus of
the truncated E-cadherin.
 
Cells and Transfection
 
MDCK clone IIG cells (Mays et al., 1995), maintained in DME supple-
mented with 10% fetal bovine serum, were transfected using the calcium
phosphate method (Graeve et al., 1990) with pSV2neo (Southern and
Berg, 1982) as the selection marker. G418 resistant (500 
 
m
 
g/ml) colonies
were isolated using cloning rings, and individual clones were expanded
and screened by immunofluorescence staining or Western blotting using
appropriate antibodies. For each construct, multiple clones were isolated
and characterized. No difference in immunofluorescence staining or West-
ern blot profile was found among clones transfected with the same con-
struct. All of the transfected MDCK cells used in this study developed
transepithelial electric resistance (TER) similar to that of parental MDCK
cells. Two independent clones of each construct were used for experi-
ments.
 
Metabolic Labeling, Immunoprecipitation, and
Related Methods
 
To monitor intracellular trafficking of newly synthesized protein, cells
were grown on 24-mm Transwellª filters for 7 d, incubated in DMEM
without Met and Cys for 1 h, and then labeled with 250 
 
m
 
Ci 
 
35
 
S-Met/Cys
(Pro-Mix; Amersham) for the time specified in individual experiments (20
min or 1 h). To metabolically label proteins to steady state, cells were la-
beled with 250 
 
m
 
Ci 
 
35
 
S-Met/Cys supplemented with 1.5 
 
m
 
g/ml of methio-
nine and 3.0 
 
m
 
g/ml of cysteine-HCl for 24 h before extraction. When re-
quired, membrane domain-specific biotinylation was performed using
NHS-SS-Biotin (Pierce) as described previously (Hammerton et al., 1991).
Labeled cells were extracted with Triton X-100 Lysis buffer (10 mM Tris-
HCl, pH 7.5, 120 mM NaCl, 25 mM KCl, 2 mM EDTA, 2 mM EGTA, and
0.5% Triton X-100) or with 1
 
3
 
 NDET extraction buffer (1% NP-40, 2%
sodium deoxycholate, 66 mM Na-EDTA, and 10 mM Tris-HCl, pH 7.4).
After treating with specific antibody bound on protein AÐSepharose
(Pharmacia), immunoprecipitates were washed with High Stringency
Buffer (HS-B): 20 mM Tris-HCl, pH 7.5, and 120 mM NaCl, 25 mM
KCl; 5 mM EDTA; 5 mM EGTA; 0.1% SDS; 1% Na-deoxycholate; 0.5%
Triton X-100, and High Salt Wash Buffer (Hs-B containing l M NaCl). If
cells were biotinylated before extraction, biotinylated immunoprecipitates
were collected with immobilized avidin (Pierce) as described previously
(Hammerton et al., 1991). Samples were then resolved by SDS-PAGE
and radioactive signals were collected by fluorography or a PhosphorIm-
ager (Molecular Dynamics). Signals were quantified with a PhosphorIm-
ager or a laser densitometer (Hoefer, San Francisco, CA).
To perform digestion of GP2CAD10 with endoglycosidase H,
GP2CAD10 MDCK cells were grown on 24-mm Transwellª filters for
7 d, labeled with 250 
 
m
 
Ci of
 
 35
 
S-Met/Cys for 24 h, then extracted with 1
 
3
 
NDET and immunoprecipitated with the monoclonal antibody against rat
GP2. Immunoprecipitates were released from protein AÐSepharose
(Pharmacia) and antibodies by boiling in 50 
 
m
 
l of 1% SDS, 200 mM 
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dithiothreitol for 5 min. An equal volume of 100 mM citric acid buffer (pH
5.5) was added to the immunoprecipitates, and 1 U of endoglycosidase H
(Boehringer Mannheim) was added and the sample was incubated at 37
 
8
 
C
for 16 h. The processed samples were resolved by 10% SDS-PAGE and
detected by fluorography.
Radioactive signals collected with a PhosphorImager were transferred
directly to Adobe Photoshop, and radioactive signals collected with fluo-
rography were scanned from autoradiography film (Kodak) into Adobe
Photoshop with a Hewlett-Packard Scan-Jet IIc scanner. The contrast of
images was adjusted in Photoshop, the images were arranged and labeled
for individual figures using Canvas 5 (Deneba Software). In some cases,
samples containing apical or basal-lateral membrane biotinylated proteins
were separated in gels with an empty lane between the sample lanes in or-
der to avoid any cross contamination of protein samples. The empty, in-
tervening lane was removed in Canvas 5 and the two sample lanes are
shown side-by-side. The rearranged images were printed using a Tek-
tronix dye sublimation printer. The printed images are representative of
the original data.
 
Size Exclusion Chromatography
 
Preparation of samples and elution of extracted proteins of MDCK cells
from Superose 6 column was preformed using identical procedures as pre-
viously published (Stewart and Nelson, 1997). The collected fractions
were resolved by 7.5% SDS-PAGE and proteins were transferred onto
nitrocellulose membranes. The membranes were then probed with a
monoclonal antibody against the extracellular domain of E-cadherin
(Transduction Laboratories) or a monoclonal antibody against 
 
b
 
-catenin
(Transduction Laboratories). After incubation with horseradish peroxi-
dase conjugated secondary antibody (Amersham), the signals were re-
corded using ECL reagent (Amersham) and autoradiography film
(Kodak).
 
Immunofluorescence Staining and Other
Staining Methods
 
For immunofluorescent staining of GP2 chimeric proteins, cells on col-
lagen coated coverslips were fixed with 3.7% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.2) at room temperature, permeabilized with 0.5%
Triton X-100 in PBS, and processed for immunofluorescence staining with
monoclonal antibody against rat GP2. NBD-ceramide (Molecular Probes)
staining of the Golgi apparatus performed on fixed MDCK cells as pub-
lished previously (Pagano et al., 1989). Acridine orange staining of lyso-
somes in live MDCK cells on coverslips was performed by adding acridine
orange (1 
 
m
 
g/ml; Sigma Chemical Co.) to growth medium for 30 min at
37
 
8
 
C, followed by incubation in normal growth medium without acridine
orange for 15 min. Then the coverslip was then mounted on a microscope
slide with spacers to form a chamber for direct observation.
Fluorescent antibody-stained cells, NBD-ceramide-stained fixed cells,
or acridine orange stained living cells were observed using a Zeiss Ax-
ioplan fluorescence microscope with a 63
 
3
 
 objective and the appropriate
filter sets. Note that for observation of acridine orange staining, the nor-
mal filter set for fluorescein isothiocyanate fluorescence was reconfigured
by replacing the barrier filter with a long pass band filter (590 nm). Fluo-
rescent images of stained cells were recorded using Kodak Tri-X film (see
Fig. 5 A) or Kodak Ektachrome Elite II (ASA 400) film (see Fig. 5, BÐD).
Photographic images were then digitized with a slide scanner (Nikon) and
resized using Adobe Photoshop. Images in Fig. 5 and Fig. 12 were ar-
ranged and labeled using Canvas 5 and printed from the computer file us-
ing a dye sublimation printer.
 
Results
 
LDL-R-like Basal-lateral Sorting Motifs Are Not 
Responsible for Basal-lateral Sorting of E-Cadherin
 
The primary structure of the cytoplasmic domain of E-cad-
herin contains two regions with amino acid sequences
and spacing that are similar to previously identified basal-
lateral sorting signals in the cytoplasmic domain of the
LDL-R (Matter et al., 1992; see Fig. 1). We assessed
whether these two motifs function as basal-lateral sorting
determinants for E-cadherin. All tyrosine residues in each
motif of canine E-cadherin were mutated into alanine in
region 1 (BL1), or region 2 (BL2), or both (BL12); similar
mutations in both motifs of LDL-R resulted in random
sorting to the cell surface in MDCK cells (Matter et al.,
1992). Each mutant was epitope-tagged with the SV-40
large T antigen epitope (KT3 tag, amino acid sequence
KPPTPPPEPET; see MacArthur and Walter, 1984) and
stably transfected into MDCK cells (Fig. 2). Confluent
monolayers of cells were grown on Transwellª filters for
7 d, and then labeled with 
 
35
 
S-Met/Cys for 1 h. At the end
of the 1 h labeling period, the first wave of newly synthe-
sized E-cadherin that arrived at the apical or basal-lateral
membrane (Shore and Nelson, 1991) was detected by cell
surface biotinylation. Mutant E-cadherin was distinguished
from endogenous E-cadherin with the KT3 monoclonal
antibody to the epitope tag.
Greater than 95% of newly synthesized mutant E-cad-
herin, lacking tyrosine residues in either region 1 (BL1), or
region 2 (BL2), or both (BL12) was delivered to the basal-
lateral domain of MDCK cells with an efficiency and fidel-
ity similar to those of endogenous E-cadherin (Fig. 2). This
result indicates that the basal-lateral sorting determi-
nant(s) of E-cadherin are different from those of LDL-R.
To further dissect basal-lateral sorting determinants in
E-cadherin, we next examined the overall localization of
the basal-lateral sorting determinant in the whole mole-
cule.
A secreted form of E-cadherin (E-cad
 
sol
 
), in which the
transmembrane (TM) and cytoplasmic (CYT) domains
had been deleted, was expressed stably in MDCK cells
(Fig. 2). Delivery of newly synthesized E-cad
 
sol
 
 to different
membrane domains was detected by sampling apical and
basal-lateral medium for 
 
35
 
S-Met/Cys labeled E-cad
 
sol
 
.
Note that E-cad
 
sol
 
 was efficiently secreted into the culture
medium, did not associate with the cell surface of MDCK
cells, and did not disrupt TER (Y.-T. Chen, unpublished
result). As shown in Fig. 2, newly synthesized E-cad
 
sol
 
 was
secreted equally into the medium of both apical and basal-
lateral compartments of the Transwellª filter. We con-
clude that the extracellular domain of E-cadherin does not
carry signals that specify E-cadherin sorting or delivery to
the basal-lateral membrane.
Figure 1. Amino acid sequence comparison of the basal-lateral
membrane sorting determinants in human LDL receptor (Matter
et al., 1992), and putative basal-lateral sorting determinant(s) in
the cytoplasmic domain of canine E-cadherin. 
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Basal-lateral Sorting Activity Resides in the 
Cytoplasmic Domain of E-Cadherin
 
To locate the basal-lateral sorting signal(s) in E-cadherin,
we constructed a chimeric protein comprising the trans-
membrane and specific regions of the cytoplasmic domain
of E-cadherin fused to the extracellular domain of GP2, a
highly glycosylated protein of zymogen granules in pan-
creatic exocrine cells (Hoops and Rindler, 1991). Nor-
mally, GP2 is attached to the membrane via a GPI anchor,
and is delivered exclusively to the apical domain of
MDCK clone II/G cells (Mays et al., 1995). A deletion mu-
tant of GP2 that lacked the GPI modification signal (Fig. 3
A, GP2
 
D
 
GPI) was expressed in MDCK cells. As shown in
 
Fig. 3 A, newly synthesized GP2
 
D
 
GPI was secreted equally
into both the apical and basal-lateral medium. This result
confirms that GP2 sorting to the apical membrane re-
quires the GPI-anchor (see Mays et al., 1995), and reveals
that the extracellular domain of GP2 does not contain spe-
cific sorting signals for the basal-lateral membrane.
GP2
 
D
 
GPI was fused to the TM and CYT of E-cadherin,
producing the chimeric protein GP2CAD1 (Fig. 3 B). Sig-
nificantly, 
 
.
 
95% of newly synthesized GP2CAD1 was
preferentially delivered to the basal-lateral domain, which
represents an efficiency and fidelity of delivery similar to
that of endogenous E-cadherin. We conclude the trans-
membrane and cytoplasmic domains of E-cadherin con-
tain a basal-lateral sorting signal(s).
Figure 2. Delivery of newly synthesized KT3
tagged E-cadherin mutants to the basal-lateral
membrane domain, and secretion of E-cadsol into
both apical and basal-lateral media. The diagram
shows schematically the structure of each mutant
constructs. The scale shows the number of amino
acid residues in the cytoplasmic domain (CYT);
the extracellular domain is not drawn to the
same scale. To examine plasma membrane deliv-
ery, cells expressing E-cadherin (E-cad), or ty-
rosine to alanine substitution mutants (E-cad
BL1, BL2, and BL12) were grown on Transwellª
filters for 7 d, labeled with 35S-Met/Cys for 1 h,
cell surface biotinylated on either the apical
(Ap) or basal-lateral (Bl) membrane, and then
processed for immunoprecipitation using the
specified antibodies (mAb KT3 against epitope
tag, or 3G8 against the extracellular domain of
canine E-cadherin) followed by immobilized avi-
din. Secretion of E-cadsol was assessed in conflu-
ent cell monolayers grown on Transwellª filters
by sampling the apical and basal-lateral media
for  35S-Met/Cys protein.
Figure 3. Dominant basal-lateral sorting activity
of E-cadherin is located in the transmembrane/
cytoplasmic domains. (A) GPI modification is
the sole determinant for targeting GP2 to the
apical membrane. GP2 has been shown previ-
ously to be preferentially delivered to the apical
domain of MDCK clone II/G cells (Mays et al.,
1995). Diagrams show schematically the struc-
ture of GP2 lacking the GPI modification signal
(GP2DGPI). GP2DGPI delivery was deter-
mined as described for E-cadsol (see Fig. 1 leg-
end, and Materials and Methods). (B) Newly
synthesized GP2CAD1, labeled for 1 h, is sorted
to the basal-lateral membrane domain, similar to
endogenous E-cadherin. Diagrams show sche-
matically the structure of GP2CAD1 compared
with E-cadherin. GP2CAD1 delivery to the cell
surface was assessed by 35S-Met/Cys labeling and cell surface biotinylation of the apical (Ap) or the basal-lateral (Bl) membrane do-
main. Note that the autoradiogram showing the E-cadherin targeting is the same as that shown in Fig. 2, and is included here for com-
parison. 
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Systematic Deletions of E-Cadherin Cytoplasmic 
Domain Result in Retarded Exit from ER and Random 
Delivery of GP2/Cadherin Chimera to the Apical and 
Basal-lateral Cell Surface
 
To map in detail the basal-lateral sorting domain of E-cad-
herin, a series of chimeric proteins were created in which
GP2
 
D
 
GPI was used as the extracellular domain (reporter)
fused to the transmembrane domain and specific regions
of the cytoplasmic domain of E-cadherin (Fig. 4). Each
mutant was designed to explore whether distinct features/
activities of the cytoplasmic domain, such as binding to
 
b
 
-catenin and individual putative sorting signals, could be
separated from each other.
In general, two types of deletion mutants were con-
structed. The first type involved the introduction of simple
truncations in the cytoplasmic domain: GP2CAD2 con-
tained amino acids (aa) 1Ð33 of the cytoplasmic domain,
and ended at the COOH terminus of the first putative
basal-lateral sorting signal (BL1); GP2CAD4 only con-
tained the first 4 aa of the cytoplasmic domain; GP2CAD6
contained aa 1Ð99 of the cytoplasmic domain, and ended
just before the start of the previously defined minimal
 
b
 
-catenin binding domain (see Introduction); GP2CAD7
contained aa 1Ð129 of the cytoplasmic domain, and ended
at the COOH terminus of the minimal 
 
b-catenin binding
domain (aa 100Ð129); GP2CAD8 contained aa 1Ð115 of
the cytoplasmic domain, and ended in the middle of the
minimal b-catenin binding domain; GP2CAD10 contained
almost all of the cytoplasmic domain except the COOH-
terminal three acidic amino acids (EDD). The second type
of mutants were loop-out mutants in which two halves of
the cytoplasmic domain were joined after an intervening
sequence had been deleted: GP2CAD3 contained a dele-
tion of aa 83Ð129 of the cytoplasmic domain (minimal
b-catenin binding domain is aa 100Ð129); GP2CAD5 con-
tained aa 83Ð129 of the cytoplasmic domain; GP2CAD9
contained aa 1Ð33 and aa 83Ð129 of the cytoplasmic do-
main. Rather unexpectedly, none of the mutants (GP2-
CAD1ÐGP2CAD10) gave distinct sorting patterns com-
pared with endogenous E-cadherin or GP2CAD1 (Fig. 4).
In all cases, mutant proteins were delivered equally to
both apical and basal-lateral membranes. Note that the
relative amounts of each chimera delivered to either the
apical or basal-lateral membrane domain are directly com-
parable, but a comparison cannot be made between the
amount of cell surface delivery of different chimeras from
these data. However, as described above, with the excep-
tion of E-cadherin and GP2CAD1, the amount of each
chimera that reached the cell surface was ,10% of that
synthesized.
To examine the subcellular location of each chimeric
protein, cells were grown on glass coverslips and processed
for immunofluorescence. An anti-GP2 antibody was used
to examine the distributions of the GP2CAD chimeras,
and to distinguish them from endogenous E-cadherin. As
shown in Fig. 5 A, GP2CAD1 was localized mainly at the
cell surface, including cellÐcell contact sites, similar to en-
dogenous E-cadherin. In contrast, staining of all other chi-
meric proteins (GP2CAD2ÐGP2CAD10) revealed an in-
tracellular, reticular staining pattern; only staining for
GP2CAD10 is shown in Fig. 5 B, but the staining of other
chimeric proteins (GP2CAD2ÐGP2CAD9) was indistin-
guishable from that of GP2CAD10 (Y.-T. Chen, unpub-
lished results). In addition, larger, punctate structures
Figure 4. Truncations of the cytoplasmic domain
of E-cadherin result in accumulation of mutant
proteins in the ER. Diagrams show schemati-
cally the structure of GP2/E-cadherin cytoplas-
mic domain chimeric constructs (GP2CAD1Ð
10). E-cadherin and GP2CAD1 diagrams are
included for comparison. E-cadherin and
GP2CAD1 data from Figs. 2 and 3 are included
for comparison. Immunofluorescence (IF) re-
vealed plasma membrane (PM) staining for
E-cadherin and GP2CAD1 while all other chi-
meric proteins (GP2CAD2Ð10) gave an intracel-
lular reticular staining pattern consistent with lo-
calization in the endoplasmic reticulum (ER).
Examples of staining are given in Fig. 5. 1 h
labeling with 35S-Met/Cys and cell surface bio-
tinylation show delivery of newly synthesized
chimeric protein to both apical (Ap) and basal-
lateral (Bl) membrane domains. b-catenin bind-
ing to GP2CAD1 and derived mutant proteins
was assessed by steady state 35S-Met/Cys labeling
for 24 h and immunoprecipitation using anti-
GP2 antibody. Examples of immunoprecipitates
of GP2CAD1, 3, 7, 8, and 10 are given in Fig. 9.
Catenin binding was not determined (ND) for
GP2CAD2, 4, and 6, because these proteins
completely lacked the minimal b-catenin binding
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were stained for GP2CAD10. The reticular pattern of
GP2CAD10 staining (Fig. 5 B), and other GP2CAD mu-
tants was very similar to that of the ER resident protein
BiP in MDCK cells (Bush et al., 1997). It was distinct from
the Golgi revealed by NBD-ceramide staining of fixed
cells (Fig. 5 C; Pagano et al., 1989), and lysosomes re-
vealed by labeling live cells with acridine orange (Fig. 5 D;
Palmgren, 1991). Thus, the majority of GP2CAD10 is
most likely localized to the ER.
To confirm biochemically that GP2CAD1 deletion mu-
tants were retained in the ER, we examined the sensitivity
of GP2CAD10 to digestion by endoglycosidase H (endo
H). GP2CAD10 MDCK cells were incubated with 35S-
Met/Cys for 24 h to label proteins to steady state. Total
cell lysates were prepared, and GP2CAD10 was immuno-
precipitated with anti-GP2 antibody and then subjected to
endo H digestion. As shown in Fig. 6, endo H digestion re-
sulted in a significant increase in electrophoretic mobility
of the major GP2CAD10 protein band. Note that the elec-
trophoretic mobility of a minor protein band (Fig. 6, aster-
isk) was not affected by incubation with endo H. This up-
per band appears to be specific to the GP2 antibody as a
minor protein with a slower electrophoretic mobility was
also present in other GP2 chimeric protein immunoprecip-
itates. It is likely that this protein band represents a small
portion (z10%) of the chimeric protein that exited the
ER and had undergone processing in the Golgi to remove
the high mannose carbohydrate chain. From the data on
the sensitivity of GP2CAD10 to endo H digestion, we con-
clude that at steady state .85% of GP2CAD10 retained
high mannose carbohydrate chains and had not undergone
further processing consistent with its location in the ER.
Truncations of E-Cadherin Cytoplasmic Domain Result 
in both Reduced Cell Surface Delivery and Random 
Sorting to Plasma Membrane Domains
The difference in staining patterns of GP2CAD1 and
GP2CAD10 (Fig. 5) might reflect differences in the effi-
ciency of protein passage through the secretory pathway.
Therefore, we compared the kinetics of cell surface deliv-
ery of newly synthesized GP2CAD1, GP2CAD10, and en-
dogenous E-cadherin (Fig. 7). MDCK cells stably express-
ing GP2CAD1 or GP2CAD10 were grown on Transwellª
filters for 7 d, pulse labeled with 35S-Met/Cys for 20 min,
and chased in DMEM containing an excess of nonradioac-
tive Met/Cys for 40 min. At the end of the chase period, ei-
ther whole cell lysates were collected, or cells were treated
with the plasma membrane-impermeant biotinylating
agent NHS-SS-biotin before lysis. Cell lysates were immu-
noprecipitated with antibody specific to rat GP2; biotin-
ylated proteins were further precipitated with immobilized
avidin. Identical experiments were performed with paren-
tal MDCK cells to examine the kinetics of endogenous
E-cadherin delivery to the plasma membrane.
As shown in Fig. 7 A, 25.9 6 1.3% of newly synthesized
endogenous E-cadherin, 23.0 6 1.8% of GP2CAD1, and
6.8 6 3.1% of GP2CAD10 reached the cell surface. Note
that the percentage of protein detected by cell surface
biotinylation represented only the fraction of newly syn-
thesized protein delivered from the ER to the plasma
membrane in the 40-min chase period. Thus, the amount
of GP2CAD1 delivered to the cell surface was similar to
that of endogenous E-cadherin, while the amount of
GP2CAD10 delivered to the cell surface was considerably
lower than that of either GP2CAD1 or E-cadherin.
The difference in the amount of cell surface delivery of
GP2CAD10 and GP2CAD1 (or endogenous E-cadherin)
was also reflected in the steady state distribution of these
proteins (Fig. 7 B). GP2CAD1 and GP2CAD10 express-
ing cells were labeled with 35S-Met/Cys to steady state for
24 h. Parallel cultures were either extracted immediately,
or biotinylated on both apical and basal-lateral mem-
branes. Biotinylated and non-biotinylated proteins were
isolated as described above. As shown in Fig. 7 B, the
amount of biotinylated cell surface GP2CAD1 was z90%
Figure 5. GP2CAD1 and GP2CAD10 show differences in sub-
cellular localization by immunofluorescence staining. Reticular
staining of GP2CAD10 (B) is distinct from cell surface staining
of GP2CAD1 (A), Golgi staining (C), and lysosomal staining
(D). Monoclonal antibody against rat GP2 was used to stain
GP2CAD1 (A) and GP2CAD10 (B) expressing MDCK cells; (C)
NBD-ceramide staining of paraformaldehyde-fixed MDCK cells;
(D) Acridine orange staining of living MDCK cells. Bar, 50 mm.
Figure 6. The majority of GP2-
CAD10 is sensitive to endoglycosi-
dase H digestion. GP2CAD10 ex-
pressing MDCK cells were grown
on Transwellª filters for 7 d, la-
beled with 35S-Met/Cys for 24 h, ex-
tracted and immunoprecipitated
with GP2 antibody. Immunoprecip-
itates were incubated in the pres-
ence (1) or absence (2) of endo H,
and were subsequently resolved by SDS-PAGE and detected by
fluorography. Only a small fraction (z10%) of GP2CAD10
(marked with asterisk) does not display an increase in electro-
phoretic mobility upon endo H treatment. Numbers at the left
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of the total GP2CAD1 extracted from cells. In contrast,
the amount of biotinylated GP2CAD10 was z7% of the
total amount of GP2CAD10. Since the extracellular do-
main of GP2CAD1 and GP2CAD10 were identical, the
difference in the amount of cell surface exposed proteins is
unlikely to be due to a difference in the efficiency of pro-
tein biotinylation. We conclude that GP2CAD1 rapidly
and efficiently exits the ER and is delivered to the basal-
lateral membrane. In contrast, z90% of GP2CAD10 is re-
tained in the ER, while the remainder slowly leaks out into
the secretory pathway and is delivered to both apical and
basal-lateral membranes.
Effects of aLLN and Chloroquine on GP2CAD1 and 
GP2CAD10 Degradation
The data presented above show that nearly all of
GP2CAD10 is retained in the ER, whereas nearly all
GP2CAD1 is localized in the plasma membrane. It is gen-
erally acknowledged that misfolded secretory proteins re-
tained in the ER are degraded through the proteasome
pathway (for a recent review, see Coux et al., 1996). To ex-
amine degradative pathways, cells were pulse-labeled with
35S-Met/Cys for 15 min and then chased in an excess of
nonradioactive Met/Cys for 225 min in the presence of ei-
ther chloroquine phosphate (a lysosome inhibitor) or
N-acetyl-Leu-Leu-norleucinal (aLLN, a 26S proteasome
inhibitor). As shown in Fig. 8 (upper panels), 70% of
newly synthesized GP2CAD1 remained at the end of the
chase period in the presence of chloroquine, compared
with 40% in its absence. By comparison, z50% of
GP2CAD10 remained in the presence of chloroquine
compared with 42% in its absence. In the presence of
aLLN (Fig. 8, bottom panels), 82% of GP2CAD1 re-
mained compared with 50% in its absence; 83% of
GP2CAD10 remained in the presence of aLLN, compared
with 60% in its absence. These results show that chloro-
quine phosphate suppressed degradation of both GP2-
CAD1 and GP2CAD10 but the effect on GP2CAD1 was
greater. On the other hand, aLLN had a more inhibitory
effect on the degradation of GP2CAD10 than did chloro-
quine, while both aLLN and chloroquine suppressed the
degradation of GP2CAD1.
E-Cadherin Binding to b-Catenin Is Coupled to 
Efficient ER Exit and Basal-lateral Membrane Delivery
The GP2CAD1 mutants were designed to test whether
binding of b-catenin to the cytoplasmic domain of E-cad-
herin and basal-lateral membrane delivery could be
separated from each other. GP2CAD1, GP2CAD5, GP2-
CAD7, GP2CAD9, and GP2CAD10 (see Fig. 4) were pre-
dicted to bind b-catenin since they contained at least aa
Figure 7. Rate of E-cadherin and GP2CAD1 delivery to the cell
surface are similar, while GP2CAD10 is delivered to the cell sur-
face at a reduced rate. At steady state, the majority of GP2CAD1
is on plasma membrane, while the majority of GP2CAD10 is in-
tracellular. (A) Arrival of newly synthesized proteins on cell sur-
face monitored by cell surface biotinylation. Cells were labeled
with 35S-Met/Cys for 20 min, chased for 40 min, cell surface bio-
tinylated, lysed, and immunoprecipitated with antibodies to ei-
ther E-cadherin (E-cad) or GP2. Aliquots of cell surface protein
(S, biotinylated, open columns) were normalized to the amount
of protein in total cell lysate (T, shaded columns). Error bars
show standard deviation (n 5 3). (B) Steady state distribution of
GP2CAD1 and GP2CAD10. Cells were labeled with 35S-Met/Cys
for 24 h, surface biotinylated on both apical and basal mem-
branes, extracted and immunoprecipitated; biotinylated proteins
were retrieved with immobilized avidin. Results show that 91.3%
(61.3%, n 5 2) of GP2CAD1 is on the cell surface, but z7.2%
(60.8%, n 5 2) of GP2CAD10 is on cell surface.
Figure 8. Effects of chloroquine phosphate (top panels) and
aLLN (bottom panels) on the degradation of GP2CAD1 (left
panels) and GP2CAD10 (right panels). Chloroquine phosphate
(CQ, 0.1 mM) treatment of cells started 1 h before pulse labeling
with 35S-Met/Cys (15 min), and aLLN (25 mM) treatment started
3 h before pulse labeling with 35S-Met/Cys (15 min). At the end of
the pulse labeling (15 min) or chase period (240 min, 15-min
pulse labeling, and 225-min chase), cells were extracted with 13
NDET, and protein was immunoprecipitated with an antibody
against rat GP2. Data for each column were from two 24-mm
Transwellª filters and the error bars show the range of the data.Chen et al. Assembly and Trafficking of the E-Cadherin/b-Catenin Complex 695
83Ð129 of the cytoplasmic domain of E-cadherin which
covers the previously defined minimal b-catenin binding
domain (aa 100Ð129; Stappert and Kemler, 1994).
The GP2CAD1/catenin complex was coimmunoprecipi-
tated with GP2 antibody and subjected to a high strin-
gency wash in buffer containing 0.1% SDS, 1% sodium
deoxycholate, and 1 M NaCl (High Stringency Wash
Buffer, see Materials and Methods). Note that under this
wash condition the stoichiometry of the coimmunoprecipi-
tated complex of GP2CAD1/b-catenin/a-catenin was z1:
1:1 (Fig. 9), similar to that of the endogenous E-cadherin/
catenin complex (Ozawa and Kemler, 1992; Hinck et al.,
1994a; see also Fig. 10). Surprisingly, we found that neither
GP2CAD10 nor GP2CAD7 bound catenins under these
conditions (Fig. 9), although both chimeras contained the
previously mapped minimal b-catenin binding domain of
E-cadherin (see Fig. 4). Similar results were obtained with
GP2CAD5 and GP2CAD9 (Y.-T. Chen, unpublished re-
sults). Catenins were not coimmunoprecipitated in a com-
plex with either GP2CAD8 (Fig. 9) in which the COOH-
terminal half of the b-catenin binding domain had been
deleted, or GP2CAD3 (Fig. 9) in which the b-catenin
binding domain had been completely deleted. Overall,
there is a strong correlation between lack of b-catenin
binding to the cytoplasmic domain of E-cadherin, and re-
tention of the majority of each GP2CAD1 mutant in the
ER. Note that Fig. 9 also reveals a difference in the appar-
ent molecular mass of GP2CAD1 and all other GP2CAD
mutants. It is likely that this is due to differences in com-
plex carbohydrate modifications between the proteins.
GP2 is known to undergo extensive N-linked glycosylation
(Hoops and Rindler, 1991). We show here that GP2CAD1
is efficiently delivered to cell surface and, thereby, re-
ceives extensive carbohydrate modifications during traf-
ficking through the secretory pathway. In contrast, all
other GP2CAD mutants are retained in the ER and,
therefore, do not undergo complex carbohydrate modifi-
cations.
We also examined b-catenin binding to E-cadherin mu-
tants in which putative basal-lateral sorting motifs has
been mutated (Tyr®Ala), and an E-cadherin chimera
formed with another protein, human CD7. Stable MDCK
cell lines expressing E-cadherin BL1, E-cadherin BL2, or
E-cadherin BL12 were labeled with 35S-Met/Cys to steady
state for 24 h, and mutant proteins were immunoprecipi-
tated with the monoclonal antibody KT3 under the strin-
gent wash conditions used above. All three Tyr-to-Ala
mutants of E-cadherin (BL1, BL2, and BL12) bound
b-catenin and a-catenin under high stringency wash condi-
tions (Fig. 10); note that these mutants were rapidly ex-
ported from the ER and sorted efficiently and specifically
to the basal-lateral membrane (Fig. 2).
We placed the putative minimal b-catenin binding do-
main (aa 83Ð129, BB1) of E-cadherin cytoplasmic domain
on the COOH terminus of a unrelated type-I transmem-
brane protein, human CD7. The resulting chimeric protein
(CD7BB1) bound a-catenin and b-catenin, whereas CD7
did not (Fig. 11; note that aliquots of the sample were re-
solved by either 7.5% or 10% SDS-PAGE in order to ob-
tain better separation of a-catenin/b-catenin and CD7/
CD7BB1, respectively). However, quantification of the
amounts of a- and b-catenins bound to CD7BB1 revealed
that the stoichiometry of CD7BB1/b-catenin/a-catenin
was 5:1:0.8 when normalized to the number of Met and
Cys residues in CD7BB1 and catenins; this compared with
the ratio of z1:1:1 for E-cadherin/b-catenin/a-catenin or
GP2CAD1/b-catenin/a-catenin (see above). Most of CD7
and CD7BB1 was localized at the cell surface (Y.-T. Chen,
unpublished results); presumably, the cytoplasmic domain
of CD7 in the CD7BB1 chimera contains signal(s) for its
entry into the secretory pathway regardless of whether
b-catenin is bound or not. Trafficking patterns of CD7 and
CD7BB1 were similar in polarized MDCK cells. Approxi-
mately 60% of the cell surface delivery of both proteins
was to the basal-lateral membrane (Y.-T. Chen, unpub-
lished results). We conclude that a domain containing aa
83Ð129 is a transportable b-catenin binding domain in
E-cadherin, but the binding strength of b-catenin/E-cad-
herin, based on high stringency washes, is much lower than
that of b-catenin bound to the complete cytoplasmic do-
main of E-cadherin. Neither the BB1 domain alone nor
b-catenin binding, per se, specifies protein delivery to the
basal-lateral membrane.
Figure 9. Catenins bind to GP2CAD1 but not GP2CAD3,
GP2CAD7, GP2CAD8, or GP2CAD10. MDCK cells expressing
individual constructs were grown on Transwellª filters for 7 d,
labeled with 35S-Met/Cys for 24 h, extracted, and proteins were
immunoprecipitated with GP2 antibody. Immunoprecipitates
were resolved by 10% SDS-PAGE. Markings to the right of col-
umns for GP2CAD10 and GP2CAD8, and those to the left of
columns of GP2CAD3 and GP2CAD7 show the positions of mo-
lecular mass markers; 116, 97, and 66 kD.
Figure 10. Catenins bind to E-cadherin and epitope tagged
(Tyr®Ala) E-cadherin mutants. Parental MDCK cells or cells
expressing individual mutant E-cadherins were grown on Trans-
wellª filters for 7 d, labeled for 24 h with 35S-Met/Cys, extracted,
and immunoprecipitated with either mAb 3G8 (against the extra-
cellular domain of canine E-cadherin) or mAb KT3 (against KT3
tag). Note that KT3 antibody immunoprecipitated nonspecifi-
cally a protein band with apparent molecular mass of z112 kD in
untransfected cells (marked with asterisk). In cells expressing
KT3 tagged E-cadherin mutants, specific bands corresponding to
E-cadherin, a-catenin, and b-catenin were detected.The Journal of Cell Biology, Volume 144, 1999 696
We also expressed a truncated E-cadherin, E-cad8 (Fig.
12), containing the complete extracellular and transmem-
brane domains, and cytoplasmic domain up to aa 115 (i.e., a
deletion of aa 116Ð151 of the cytoplasmic domain), which
is identical to the COOH-terminal deletion in GP2CAD8
(see Fig. 4). This deletion covers the minimal b-catenin
binding site (Stappert and Kemler, 1994), and b-catenin is
not coimmunoprecipitated in a complex with E-cad8 (data
not shown) as reported previously (Stappert and Kemler,
1994). E-cad8 was epitope tagged at its COOH terminus
with the KT3 epitope tag, which enabled us to distinguish
its distribution in cells expressing endogenous E-cadherin.
In confluent monolayers of MDCK cells, in which cellÐcell
contacts are clear (Fig. 12 B), E-cad8 is not apparent at
cellÐcell contacts but is localized to intracellular compart-
ments. The staining patterns comprise bright, punctate
structures that are present, although less abundant in cells
expressing GP2CAD10 (Fig. 5 B), and a diffuse cytoplas-
mic staining also similar to that of GP2CAD10 (Fig. 5 B).
The extracellular and membrane proximal cytoplasmic do-
mains of cadherin have been proposed to be involved in
dimer formation (Shapiro et al., 1995; Nagar et al., 1996;
Brieher et al., 1996; Yap et al., 1998). To test whether E-cad8
interacted with endogenous E-cadherin, we separated pro-
teins extracted from MDCK cells expressing E-cad8 using
a Superose 6 size exclusion column. Endogenous E-cad-
herin eluted in fractions 13Ð16 (Fig. 12 C, see legend for
details), as shown previously (Stewart and Nelson, 1997).
However, E-cad8 eluted in fractions 16Ð19 in a profile dis-
tinctively different from that of endogenous E-cadherin
(Fig. 12 C). Note that E-cad8 has an apparent molecular
mass smaller than that of full-length E-cadherin, which is
consistent with the cytoplasmic domain deletion. A pro-
tein band with an apparent molecular mass greater than
that of the full-length E-cadherin probably represents the
precursor form of E-cad8 (Ozawa and Kemler, 1990). We
also found an enrichment of higher molecular mass pre-
cursor forms of three other E-cadherin cytoplasmic do-
main deletion mutants when expressed in MDCK cells
(data not shown).
Discussion
How membrane proteins are sorted and delivered to dif-
ferent plasma membrane domains in polarized epithelial
cells is an important question. However, to date most stud-
ies have focused on single proteins that do not form a com-
plex with subunit membrane or cytosolic proteins during
their transit through the secretory pathway. Although
these studies have identified several types of intrinsic
basal-lateral sorting signals in the cytoplasmic domain of a
Figure 11. Catenins bind
weakly to CD7BB1. MDCK
cells expressing human CD7,
or the chimeric protein
CD7BB1 were grown on
Transwellª filters for 7 d, la-
beled for 24 h with 35S-Met/
Cys, extracted with Triton
X-100 lysis buffer, and im-
munoprecipitated with mono-
clonal antibody T3.3A1
(against the extracellular do-
main of human CD7). Identi-
cal samples were resolved by
7.5% or 10% SDS-PAGE to
obtain better separation of
CD7/CD7BB1 and catenins, respectively. Numbers at the right
mark the positions of molecular mass in kD.
Figure 12. Intracellular localization and size
exclusion column elution profile of E-cad8
are distinctively different from those of full-
length E-cadherin. (A) Schematic diagram of
E-cad8 compared with full-length E-cad-
herin. The COOH-terminal 36 aa of E-cad-
herin are deleted in E-cad8. This deletion is
equivalent to the deletion in GP2CAD8 (Fig.
4). The KT3 epitope tag was fused at the
COOH terminus of the cytoplasmic domain of
E-cad8.  EXT, extracellular domain; TM,
transmembrane domain; BB, b-catenin bind-
ing domain. Note the diagram is not to scale.
(B) Immunofluorescence staining of E-cad8
in MDCK cells using monoclonal antibody
KT3. Bar, 50 mm. (C) Elution profile of full-
length E-cadherin, E-cad8, and b-catenin af-
ter Superose 6 size exclusion chromatogra-
phy. Individual fractions were resolved by
SDS-PAGE and proteins were probed with a
monoclonal antibody against the extracellu-
lar domain of E-cadherin or a monoclonal
antibody against b-catenin. The numbers
given on top of the gels are the fraction num-
bers. Note that there are three polypeptide bands in the MDCK E-cad8/E-cadherin Western blot. E-cad8 has an electrophoretic mobil-
ity faster than that of full-length E-cadherin, which is consistent with the cytoplasmic domain deletion. Full-length E-cadherin is the
middle polypeptide band. A protein band with an electrophoretic mobility slower than that of the full-length E-cadherin probably
represents the precursor form of E-cad8. T, total cell lysate.Chen et al. Assembly and Trafficking of the E-Cadherin/b-Catenin Complex 697
few proteins (Matter and Mellman, 1994), it is not known
whether they can be generalized to transmembrane pro-
teins with heterologous binding partners.
E-cadherin is different from other type-I single-span
transmembrane protein that have been used to study sort-
ing signals, since it forms a 1:1:1 stoichiometric complex
with two cytosolic proteins, b-catenin and a-catenin
(Ozawa and Kemler, 1992). Significantly, previous studies
implied that assembly of the E-cadherin/b-catenin com-
plex occurs in the very early stage of trafficking (Ozawa
and Kemler, 1992; Hinck et al., 1994a; this study). There-
fore, E-cadherin must be sorted to the basal-lateral mem-
brane in a complex with b-catenin. Amino acid sequences
in the cytoplasmic domain of E-cadherin that are superfi-
cially similar to recently described ER exit (Nishimura and
Balch, 1997) and basal-lateral sorting signals (Matter et al.,
1992) in other proteins do not have these functions in
E-cadherin. Instead, assembly of the E-cadherin/b-cate-
nin complex is the obligatory step in efficient export from
the ER, and subsequent delivery of E-cadherin to the
basal-lateral membrane of polarized MDCK cells.
Defining the b-Catenin Binding Site in E-Cadherin
To examine domains of E-cadherin important in its sorting
to the basal-lateral membrane domain, we used a chimeric
protein approach. The chimera was composed of the ex-
tracellular domain of GP2, which is normally attached to
the membrane through a GPI-anchor, fused to the trans-
membrane and cytoplasmic domains of E-cadherin (GP2-
CAD1). The extracellular domain of GP2, when expressed
without a membrane anchor, was secreted equally from
both apical and basal-lateral membranes, showing that this
domain does not contain specific membrane sorting sig-
nals. Using a similar approach, we showed that the extra-
cellular domain of E-cadherin does not contain signals
that specify sorting to the basal-lateral membrane. The
chimeric protein GP2CAD1, however, was delivered di-
rectly to the basal-lateral membrane domain with a rate,
efficiency and fidelity similar to that of endogenous E-cad-
herin.
GP2CAD1 also formed a complex with a- and b-catenin
with a stoichiometry of z1:1:1 that was resistant to disrup-
tion with a high stringency buffer containing 0.1% SDS,
1% deoxycholate and 1 M NaCl, similar to E-cadherin.
The design of truncation mutants of GP2CAD1 used to
examine sorting signals in the cytoplasmic domain of
E-cadherin took into account a previously defined mini-
mal b-catenin binding domain that had been mapped to a
region of 30 aa, corresponding to aa 100Ð129 (Stappert and
Kemler, 1994). However, we found that b-catenin did not
bind, under these stringent conditions, to a slightly longer
region containing this minimal b-catenin binding domain,
aa 83Ð129, if regions of the cytoplasmic domain around it
had been deleted (e.g., GP2CAD5, 7, 9, and 10).
We tested whether this difference between our results
and those of Stappert and Kemler (1994) reflected the dif-
ference in the cell types used to express these mutants (L
cells, MDCK cells). GP2CAD1, 6, 7, 8, and 10 were tran-
siently transfected into L cells and HEK293 cells. By im-
munofluorescence in both cell types, GP2CAD1 was local-
ized to the cell surface, whereas GP2CAD6, 7, 8, and 10
were predominantly localized to the ER (Y.-T. Chen, un-
published results), similar to their locations in MDCK cells
(summarized in Fig. 4). Another reason for the difference
in results might be the methods used to assess the stoichi-
ometry of b-catenin binding to this minimal binding site
on E-cadherin. However, Stappert and Kemler (1994), did
not quantitate the stoichiometry of the complex formed
between b-catenin and the minimal b-catenin binding do-
main (aa 100Ð129). We found that b-catenin bound to a
chimeric protein composed of CD7 and aa 83Ð129 of the
E-cadherin cytoplasmic domain (CD7BB1), but the stoi-
chiometry of the coimmunoprecipitated complex was z5:1
after a high stringency wash. Recently, Finnemann et al.
(1997) reported the expression of three COOH-terminal
deletion mutants of Xenopus XB/U-cadherin in L cells. A
deletion of the most COOH-terminal 19 amino acids,
which would contain the minimal b-catenin binding do-
main intact, bound b-catenin but the adhesion function of
the truncated cadherin was interpreted to be Òdramatically
altered.Ó We note that biochemical data presented in the
same paper (Fig. 3 in Finnemann et al., 1997) revealed a
decrease in the avidity of b-catenin binding to the mutant
cadherin. Interestingly, confocal microscopy of L cells ex-
pressing XB/U-cadherin revealed that full-length protein
localized to cellÐcell contacts, whereas the truncation mu-
tant had a distinctly different location and appeared to
have a punctate distribution. In conclusion, it seems likely
that b-catenin binds to a minimal domain of E-cadherin
comprising aa 100Ð129, but the interaction is considerably
weaker than binding of b-catenin to the whole cytoplasmic
domain of E-cadherin. Reduced binding of the cytoplas-
mic domain of cadherin to b-catenin leads to intracellular
retention and reduced cell surface expression of cadherin.
The cadherin-binding domain in b-catenin lies within
the armadillo (arm) repeats of b-catenin (Hulsken et al.,
1994). The crystal structure of the arm repeats revealed a
rigid cylindrical super-helix of helices that form a groove
lined with positively-charged amino acids (Huber et al.,
1997). The length of this groove could potentially accom-
modate a fully extended peptide of aa 25Ð30, or a longer
peptide with local secondary structures; note that the min-
imal b-catenin binding site on E-cadherin is 29 aa and has
a pI of 3.1 (see Huber et al., 1997). Although structural
analysis of the E-cadherin/b-catenin cocrystal is required
to define the interaction in detail, our recent analysis has
revealed that the cytoplasmic domain of E-cadherin is pro-
tected from proteolysis when it has formed a 1:1 stoichio-
metric complex with the b-catenin arm repeats (Huber,
A., D.B. Stewart, W.J. Nelson, and W. Weis, in prepara-
tion). This result is compatible with the view formed from
the present studies of b-catenin binding to GP2CAD1 de-
letion mutants in which most of the cytoplasmic domain of
E-cadherin, including the previously mapped minimal
b-catenin binding domain, interacts with b-catenin.
b-Catenin/E-Cadherin Binding Is Coupled to Efficient 
Exit of E-Cadherin from the ER
Using a combination of results obtained by cell surface
biotinylation, sensitivity to endoglycosidase H digestion,
immunoprecipitation, and immunofluorescence we have
shown that GP2CAD1 bound b-catenin and .90% en-The Journal of Cell Biology, Volume 144, 1999 698
tered the secretory pathway to the basal-lateral mem-
brane. However, GP2CAD1 deletion mutants did not bind
a- or b-catenin and .90% remained in the ER. Previous
studies indicated that newly synthesized E-cadherin binds
b-catenin soon after its synthesis, and that a-catenin binds
to the complex when E-cadherin arrives at the cell surface
(Ozawa and Kemler, 1992; Hinck et al., 1994a). Thus, for-
mation of the E-cadherin/b-catenin complex correlates
with efficient exit of E-cadherin from the ER.
It is possible that E-cadherin has a specific ER export
signal that is deleted from the GP2CAD1 mutants. Re-
cently, it was reported that the COOH-terminal acidic res-
idues of VSV-G protein are involved in efficient exit of
VSV-G protein from ER (Nishimura and Balch, 1997),
and that deletion of the most COOH-terminal two valine
residues of proTGFa resulted in the ER accumulation of
the protein (Briley et al., 1997). It has been suggested that
COOH-terminal acidic amino acid residues constitute an
ER export signal (Nishimura and Balch, 1997). In this
regard, it is striking that our results showed that a deletion
of the COOH-terminal three acidic amino acids of GP2-
CAD1 resulted in the accumulation of the protein (GP2-
CAD10) in the ER. However, our data are not consistent
with the possibility that these, or other acidic amino acids
at the COOH terminus constitute a minimal ER exit sig-
nal. Internal deletions of the cytoplasmic domain of E-cad-
herin (e.g., GP2CAD3) resulted in retention of the protein
in the ER, even though COOH-terminal acidic amino ac-
ids were intact. In general, we cannot separate the roles of
different regions/motifs as ER export signals from the
dominant requirement for high affinity binding of b-cate-
nin to the whole cytoplasmic domain of E-cadherin. It
seems more likely that the complex of E-cadherin/b-cate-
nin presents a conformation or motif in the cytoplasmic
domain of E-cadherin that allows efficient export of the
complex from the ER. Definitive proof of this mechanism
will require the expression of E-cadherin in a cell line
lacking both b-catenin and plakoglobin. ER retention of
GP2CAD1 proteins containing a truncated cytoplasmic
domain is likely to be a consequence of missfolding, due to
inhibition of b-catenin binding (see Fig. 9). These mis-
folded proteins are targeted subsequently for degradation
in either lysosomes or the 26S proteasome (Fig. 8). Finally,
our analysis of the distribution of the simple deletion mu-
tant E-cad8 (Fig. 12), which was not a chimeric protein,
showed that this mutant was also localized intracellularly.
E-cad8 did not form a complex with endogenous E-cad-
herin despite an intact extracellular and membrane proxi-
mal cytoplasmic domain, which have been identified as po-
tential sites for dimer formation (Shapiro et al., 1995; Nagar
et al., 1996; Brieher et al., 1996; Yap et al., 1998). Thus,
E-cadherin dimerization may not occur in the absence of
b-catenin binding, or is dependent on E-cadherin leaving
the ER or arriving at the plasma membrane.
b-Catenin Binding to E-Cadherin and Delivery of
E-Cadherin to Sites of Function in the Basal-lateral 
Membrane Domain of the Cell Surface
Previous studies have emphasized that sorting of trans-
membrane proteins to either the apical or basal-lateral
membrane occurs in the TGN (Matter and Mellman,
1994). For example, early studies showed that influenza vi-
rus HA and VSV-G protein appeared together in vesicles
and membrane compartments until the TGN where they
appeared to be segregated into separate vesicle popula-
tions (Fuller et al., 1985). Our data show that complex for-
mation between E-cadherin cytoplasmic domain and
b-catenin in the ER is not only coupled to efficient export
of E-cadherin but also direct delivery of E-cadherin to the
basal-lateral membrane. Note that in the absence of com-
plex formation with b-catenin, a small amount (,10%) of
GP2CAD1 deletion mutants leaked out of the ER and
were then delivered randomly to both the apical and
basal-lateral membranes. As in the case of ER export, we
suggest that binding of b-catenin to E-cadherin induces a
conformation state in the cytoplasmic domain of E-cad-
herin that reveals a sorting determinant(s) that is recog-
nized by the basal-lateral sorting machinery. Thus, b-cate-
nin may function as a chauffeur to facilitate E-cadherin
transport through the secretory pathway. At present, we
cannot rule out an alternative possibility that b-catenin it-
self contains basal-lateral membrane targeting informa-
tion, and that this information is recognized by the sorting
machinery for delivery of the E-cadherin/b-catenin com-
plex to the basal-lateral membrane.
That binding of b-catenin to the cytoplasmic domain of
E-cadherin plays an essential role in the efficient delivery
of E-cadherin to the cell surface raises the interesting pos-
sibility that ER exit is a potential regulatory point for
E-cadherin function. For example, limited availability of
b-catenin for binding to E-cadherin, or post-translational
modifications to b-catenin that reduce the affinity of
E-cadherin/b-catenin binding might lead to the retention
of un-complexed E-cadherin in the ER. Since the half-life
of E-cadherin is quite short (,5 h in MDCK cells; Shore
and Nelson, 1991), retention of newly synthesized E-cad-
herin in the ER would quickly result in reduced cell sur-
face expression of E-cadherin and, consequently, reduced
cellÐcell adhesion. We note that b-catenin is a component
of the Wnt/Wingless signaling pathway in which regulation
of b-catenin levels is critical (Cadigan and Nusse, 1997).
Significantly, there is evidence that changes in b-catenin
levels leads to changes in steady state and cell surface lev-
els of cadherins, and increased cadherin-mediated cellÐcell
adhesion (Bradley et al., 1993; Hinck et al., 1994b; Yana-
gawa et al., 1997). These effects on cadherin could be me-
diated by the availability of b-catenin for binding to cad-
herin in the ER, which regulates cadherin entry into the
secretory pathway and, therefore, the amount of cadherin
available for adhesion functions at the cell surface.
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